ILCA – ONLINE – The International Liver Cancer Association

Register for free!

Membership

Y-ILCA Committee

Submit your abstract!

Welcome To ILCA – International Liver Cancer Association

The International Liver Cancer Association (ILCA) is the only international organisation devoted exclusively to liver cancer research for experts from all related disciplines.

ILCA’s mission is to lead a global community of physicians, scientists and allied professionals through education and research, with the goal to better prevent and treat liver cancer.

Liver Cancer Community

Hours of Education

Countries
Reached

ILCA Conference Attendees

Hours of Education

Countries Reached

LATEST NEWS

News

ILCA 2022 Call for Abstracts Open!

20/01/2022

News

Be part of the ILCA community this 2022

06/01/2022

News

Happy Holidays!

21/12/2021

News

Join the biggest Liver Cancer Community

23/11/2021

PUBLICATIONS

Final overall survival efficacy results of ivosidenib for patients with advanced cholangiocarcinoma with IDH1 mutation – The phase 3 randomized clinical ClarIDHy trial

23/09/2021

Safety, efficacy, and pharmacodynamics of tremelimumab plus durvalumab for patients with unresectable hepatocellular carcinoma: randomized expansion of a phase I/II study

20/09/2021

NASH limits anti-tumour surveillance in immunotherapy-treated HCC.

07/06/2021

Second-line FOLFOX chemotherapy versus active symptom control for advanced biliary tract cancer (ABC-06): a phase 3, open-label, randomised, controlled trial.

07/06/2021

ILCAFollow

The International Liver Cancer Association (ILCA) is the only international organisation devoted to liver cancer for experts from all related disciplines.

Retweet on Twitter ILCA Retweeted

Avatar massimo iavarone @massimoiava·

26 Jan

#cholangiocarcinoma #livercancer #CCA @AASLDtweets @ILCAnews @JesusMBanales @MarioStrazzabos @chiarabraconi @MarcoMarzioni74 @Alexfornergon... https://twitter.com/HEP_Journal/status/1486398782346432512

HEPATOLOGY Journal@HEP_Journal

Lin et al. demonstrate that #CAFs:
Educate MDSCs
⬆️ activity of 5-lipoxygenase in MDSCs
Promote cancer stemness via LTB4-BLT2 axis
#LiverTwitter @bruixj @massimoiava
https://aasldpubs.onlinelibrary.wiley.com/doi/epdf/10.1002/hep.32099

Twitter 1486421476815298561

Avatar ILCA @ILCAnews·

26 Jan

ILCA's Guidances broaden awareness and deepen knowledge about recent research diagnosis and treatment of liver cancer.
Last year, our ... experts published a Systemic Therapy Guidance and a Biomarker Development for Hepatocellular Carcinoma.
Find out more: https://ilca-online.org/education/ilca-guidances/

Twitter 1486362225287872514

Avatar ILCA @ILCAnews·

25 Jan

Following the recent presentation of the HIMALAYA trial at @ASCO GI and COSMIC 312 trial at @myESMO Asia, leading investigators @GABOUALFA, ... @LorenzaRimassa and @ArndtVogel present the latest data and discuss the implications for clinical practice.
Sign up: https://register.gotowebinar.com/register/2183654702189643275

Twitter 1485970818702131208